Genotype-phenotype correlations in disorders of peroxisome biogenesis

Molecular Genetics and Metabolism

Volumn 68, Issue 2, 1999, Pages 316-327

  Moser, Hugo W ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Peroxisomes; biogenesis; peroxins; mutations; rhizomelic chondrodysplasia punctata; Zellweger syndrome; neonatal adrenoleukodystrophy; infantile Refsum's disease

Indexed keywords

FATTY ACID; PLASMALOGEN;

ADRENOLEUKODYSTROPHY; BIOGENESIS; CHONDRODYSPLASIA PUNCTATA; ENZYME DEFECT; FATTY ACID OXIDATION; GENE MUTATION; GENETIC COUNSELING; GENETIC HETEROGENEITY; HUMAN; MOSAICISM; PEROXISOME; PRIORITY JOURNAL; REFSUM DISEASE; SHORT SURVEY; ZELLWEGER SYNDROME;

EID: 0032729864     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2926     Document Type: Article

References (87)

1. van den Bosch H, Schutgens R BH, Wanders R JA, Tager J M. Biochemistry of peroxisomes. Annu Rev Biochem. 61:1992;157-197.
2. Moser H W. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain. 120:1997;1485-1508.
3. Dubois-Dalcq M, Feigenbaum V, Aubourg P. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci. 22:1999;4-12.
4. Wanders R JA, Tager J M. Lipid metabolism in peroxisomes in relation to human disease. Molec Aspects Med. 19:1998;71-154.
5. Wanders R JA, Dekker C, Hovarth V AP, Schutgens R BH, Tager J M, Van Laer P, Lecoutere D. Human alkyldihydroxyacetonephosphate synthase deficiency: A new peroxisomal disorder. J Inher Metab Dis. 17:1994;315-318.
6. Wanders R JA, Schumacher H, Heikoop J, Schutgens R BH, Tager J M. Human dihydroxyacetonephosphate acyltransferase deficiency: A new peroxisomal disorder. J Inher Metab Dis. 15:1992;389-391.
7. Jansen G A, Ofman R, Ferdinandusse S, Ijlst L, Muijsers A O, Skjeldal O H, Stokke O, Jakobs C, Besley G TN, Wraith J E, Wanders R JA. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nature Genet. 17:1997;190-193.
8. Mihalik S J, Morell S J, Kim D, Watkins P A, Gould S J. Identification of PAHX, a Refsum disease gene. Nature Genet. 17:1997;185-189.
9. Lazarow P B, Fujiki Y. Biogenesis of peroxisomes. Annu Rev Cell Biol. 1:1985;489-530.
10. Elgersma Y, Tabak H F. Proteins involved in peroxisome biogenesis and functioning. Biochim Biophys Acta. 1286:1996;269-283.
11. Subramani S. Components involved in peroxisome biogenesis, proliferation, turnover and movement. Physiol Rev. 78:1998;171-188.
12. Gould S J, Keller G-A, Hosken N, Wilkinson J, Subramani S. A conserved tripeptide sorts proteins to peroxisomes. J Cell Biol. 108:1989;1657-1664.
13. Swinkels B W, Gould S J, Bodnar A G, Rachubinski R A, Subramani S. A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 10:1991;3255-3262.
14. Authier F, Bergeron J M, Ou W J, Rabushinski R, Posner B I, Walton P A. Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase. Proc Natl Acad Sci USA. 92:1995;3859-3863.
15. deVet E CJM, Lodewijk I J, Oostheim W, Wanders R J, van den Bosch H. Alkyl-dihydroxyacetonephosphate synthase: Fate in peroxisome biogenesis disorders and identification of the point mutation underlying a single enzyme deficiency. J Biol Chem. 273:1998;10296-10301.
16. van der Klei, Veenhuis M. Yeast peroxisomes: Function and biogenesis of a versatile cell organelle. Trends Microbiol. 5:1997;502-509.
17. Shimozawa N, Tsukamoto T, Suzuki Y, Orii T, Shirayoshi Y, Mori T, Fujiki Y. A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science. 255:1992;1132-1134.
18. Dodt G, Braverman N, Wong C, Moser A, Moser H W, Watkins P A, Valle D, Gould S. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nature Genet. 9:1995;115-125.
19. Distel B, Erdmann R, Gould S J, Blobel G, Crane D I, Cregg J M, Dodt G, Fujiki Y, Goodman J M, Just W W, Kiel J AKW, Kunau W H, Lazarow P B, Mannaerts G P, Moser H W, Osumi T, Rachubinski R A, Roscher A, Subramani S, Tabak H F, Tsukamoto T, Valle D, van der Klei I, van Veldhoven P P. A unified nomenclature for peroxisome biogenesis factors. J Cell Biol. 135:1996;1-3.
20. Bowen P, Lee C SN, Zellweger H, Lindenberg R. A familial syndrome of multiple congenital defects. Bull Johns Hopkins Hosp. 114:1964;402-414.
21. Zellweger H. The cerebro-hepato-renal (Zellweger) syndrome and other peroxisomal disorders. Dev Med Child Neurol. 29:1987;821-829.
22. Ulrich J, Hershkowitz N, Heits P, Sigrist T, Baerlocher P. Adrenoleukodystrophy: Preliminary report of a connatal case, light- and electron microscopical, immunohistochemical and biochemical findings. Acta Neuropathol (Berl). 43:1978;77-83.
23. Scotto J M, Hadchouel M, Odievre M, Laudat M H, Saudubray J M, Dulac O, Beucler I, Beaune P. Infantile phytanic acid storage disease: A possible variant of Refsum's disease: Three cases, including ultrastructural studies of the liver. J Inher Metab Dis. 5:1982;83-90.
24. Spranger J W, Opitz J M, Bidder U. Heterogeneity of chondrodysplasia punctata. Humangenetik. 11:1971;190-212.
25. Goldfischer S, Moore C L, Johnson A B, Spiro A J, Valsamis M P, Ritch R H, Wisniewski H K, Norton W T, Rapin I, Gartner L M. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science. 182:1973;62-64.
26. Danks D M, Tippett P, Adams C, Campbell P. Cerebro-hepato-renal syndrome of Zellweger: A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. J Pediatr. 86:1975;382-387.
27. Heymans H SA, Schutgens R BH, Tan R, van den Bosch H, Borst P. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature. 306:1983;69-70.
28. Heymans H SA, Oorthuys J WE, Nelck G, Wanders R JA, Schutgens R BH. Rhizomelic chondrodysplasia punctata: Another peroxisomal disorder. N Engl J Med. 313:1985;187-188.
29. Brown F R III, McAdams A J, Cummins J W, Konkol R, Singh I, Moser A B, Moser H W. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: Similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J. 151:1982;344-351.
30. Brul S, Westerveld A, Strijland A, Wanders R JA, Schram A W, Heymans H SA, Schutgens R BH, van den Bosch H, Tager J M. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions - A study using complementation analysis. J Clin Invest. 81:1988;1710-1715.
31. Moser A B, Rasmussen M, Naidu S, Watkins P A, McGuinness M, Hajra A K, Chen G, Raymond G, Liu A, Gordon D, Garnaas K, Walton D S, Skjeldal O H, Guggenheim M A, Jackson L G, Elias E R, Moser H W. Phenotype of patients with peroxisomal disorders subdivided into 16 complementation groups. J Pediatr. 127:1995;13-22.
32. Wanders R JA, Mooijer P AW, Dekker C, Suzuki T, Shimozawa N. Disorders of peroxisome biogenesis: Complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX 1 deficiency). J Inher Metab Dis. 22:1999;314-318.
33. Shimozawa N, Suzuki Y, Zhang Z, Kinoshita N, Fujiki Y, Tsukamoto T, Osumi T, Imanaka T, Orii T, Beemer F, Mooijer P, Dekker C, Wanders R JA. Genetic basis of peroxisome-assembly mutants of humans, Chinese hamster ovary cells, and yeast: Identification of a new complementation group of peroxisome-biogenesis disorders apparently lacking peroxisomal-membrane ghosts. Am J Hum Genet. 1963.
34. Baumgartner M R, Poll-The B T, Verhoeven N M, Jakobs C, Espeel M, Roels F, Rabier D, Levade T, Rolland M O, Martinez M, Wanders R JA, Saudubray J M. Clinical approach to inherited peroxisomal disorders: A series of 27 patients. Ann Neurol. 44:1998;720-730.
35. Theil A C, Schutgens R BH, Wanders R JA, Heymans H SA. Clinical recognition of patients affected by a peroxisomal disorder: A retrospective study in 40 patients. Eur J Pediatr. 151:1992;117-120.
36. Burdette D E, Kremser K, Fink J K, Pahan K, Stanley W, Singh I. Late-onset generalized disorder of the peroxisome. Neurology. 46:1996;829-831.
37. Van Grunsven E G, van Berkel E, Ijlst L, Vreken P, deKlerk J BC, Adamsky J, Lemonds H, Clayton P T, Guebas D A, Wanders R JA. Peroxisomal d-hydroxyacyl-CoA dehydrogenase deficiency: Resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proc Natl Acad Sci USA. 95:1998;2128-2133.
38. Goldfischer S, Collins J, Rapin I, Neumann P, Neglia W, Spiro A J, Ishii T, Roels F, Vamecq J, Van Hoof F. Pseudo-Zellweger syndrome: Deficiencies in several peroxisomal oxidative activities. J Pediatr. 108:1986;25-32.
39. Schram A W, Goldfischer S, van Roermund C T, Brouwer-Kelder E M, Collins J, Hashimoto T, Heymans H SA, van den Bosch H, Schutgens R BH, Tager J M, Wanders R JA. Human Peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci USA. 84:1987;2494-2496.
40. Poll-The B T, Roels F, Ogier H, Scotto J, Vamecq J, Schutgens R BH, Wanders R JA, van Roermund C WT, van Wijland M JA, Schram A J, Tager J M, Saudubray J-M. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of Acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet. 42:1988;422-434.
41. Reuber B E, Germain-Lee E, Collins C S, Morrell J C, Ameritunga R, Moser H W, Valle D, Gould S J. Mutations of PEX1 are the most common cause of peroxisome biogenesis disorders. Nature Genet. 17:1997;445-448.
42. Confalonieri F, Duguet M. A 200-amino acid ATPase module in search of a basic function. Bioessays. 17:1995;639-650.
43. McCollum D, Monosov E, Subramani S. The pas8 mutant of pichia pastoris exhibits the peroxisome protein import deficiencies of Zellweger syndrome cells - The PAS8 protein binds to the COOH-terminal tripeptide peroxisomal targeting signal, and is a member of the TPR protein family. J Cell Biol. 121:1993;761-774.
44. Portsteffen H, Beyer A, Becker E, Epplen C, Pawlak A, Kunau W-H, Dodt G. Human PEX is mutated in complementation group 1 of the peroxisomal disorders. Nature Genet. 17:1997;449-452.
45. Tamura S, Okumoto K, Toyama R, Shimozawa N, Tsukamoto T, Suzuki Y, Osumi T, Kondo N, Fujiki Y. Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group 1. Proc Natl Acad Sci USA. 95:1998;4350-4355.
46. Gartner J, Preuss N, Brosius U, Biermanns M. Mutations in PEX1 in peroxisome biogenesis disorders: G843D and a mild clinical phenotype. J Inher Metab Dis. 22:1999;311-313.
47. Imamura A, Tamura S, Shimozawa N, Suzuki T, Zhang Z, Tsukamoto T, Orii T, Kondo N, Osumi T, Fujiki Y. Temperature-sensitive mutation in PEX1 moderates the phenotype of peroxisome deficiency disorders. Hum Molec Genet. 7:1998;2089-2094.
48. Collins C S, Gould S J. Identification of a common PEX1 mutation in Zellweger syndrome. Hum Mutat. 14:1999;45-53.
49. Braverman N, Dodt G, Gould S J, Valle D. An isoform of Pex5p, the human PTS1 receptor, is required for the import of PTS2 proteins into the peroxisomes. Hum Mol Genet. 7:1998;1195-1198.
50. Braverman N, Steel G, Obie C, Moser A, Moser H, Gould S J, Valle D. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nature Genet. 15:1997;369-376.
51. Otera H, Okumoto K, Tateishi K, Ikoma T, Matsuda E, Nishimura M, Tsukamoto T, Osumi T, Ohashi K, Higuchi O, Fujiki Y. Peroxisome targeting signal type 1 (PTS1) receptor is involved in import of both PTS1 and PTS2: Studies with PEX5-defective CHO cell mutants. Mol Cell Biol. 18:1998;388-399.
52. Fukuda S, Shimozawa N, Suzuki Y, Zhang Z, Tomatsu S, Tsukamoto T, Hashiguchi N, Osumi T, Masuno M, Imaizumi K, Kuroki Y, Fujiki Y, Orii T, Kondo N. Human peroxisomal assembly factor-2 (PAF-2): A gene responsible for group C peroxisome biogenesis disorder in humans. Am J Hum Genet. 59:1996;1210-1220.
53. Geisbrecht B V, Collins C S, Reuber B E, Gould S J. Disruption of a PEX1-PEX6 interactions is the most common cause of the neurologic disorder Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. Proc Natl Acad Sci USA. 95:1998;8630-8635.
54. Zhang Z, Suzuki Y, Shimozawa N, Fukuda S, Imamura A, Tsukamoto T, Psumi T, Fujiki Y, Orii T, Wanders R JA, Barth P G, Moser H W, Paton B C, Besley G T, Kondo N. Genomic structure and identification of 11 novel mutations of the PEX6 (Peroxisome Assembly Factor-2) gene in patients with peroxisome biogenesis disorders. Hum Mutat. 13:1999;487-496.
55. Warren D S, Morrell J C, Moser H W, Valle D, Gould S J. Identification of PEX10, the gene defective in complementation group 7 of the peroxisome biogenesis disorders. Am J Hum Genet. 63:1998;347-359.
56. Okumato K, Itoh R, Shimozawa N, Suzuki T, Tamura S, Kondo N, Fujiki Y. Mutations in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. Hum Mol Genet. 7:1998;1399-1405.
57. Okumoto K, Shimozawa N, Kawai A, Tamura S, Tsukamoto T, Osumi T, Moser H W, Wanders R JA, Suzuki T, Kondo N, Fujiki Y. PEX12, the pathogenetic gene in group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patients analysis and characterization of Pex12p. Mol Cell Biol. 18:1998;4324-4336.
58. Chang C C, Gould S J. Phenotype-genotype relationships in complementation group 3 of the peroxisome biogenesis disorders. Am J Hum Genet. 63:1998;1294-1306.
59. Okumoto K, Fujiki Y. PEX12 encodes an integral membrane protein of peroxisomes. Nature Genet. 17:1997;265-266.
60. Baumgartner M R, Verhoeven N M, Jacobs C, Roels F, Espeel M, Martinez M, Rabier D, Wanders R JA, Saudubray J M. Defective peroxisomal biogenesis with a neuromuscular disorder resembling Werdnig-Hoffman disease. Neurology. 51:1998;1427-1432.
61. Erdmann R, Blobel G. Identification of Pex13p, a peroxisomal membrane receptor for the PTS1 recognition factor. J Cell Biol. 135:1996;111-121.
62. Bjorkman J, Stetten G, Moore C S, Gould S J, Crane D I. Genomic structure of PEX13, a candidate peroxisome biogenesis disorder gene. Genomics. 54:1998;521-528.
63. Shimozawa N, Suzuki Y, Zhang Z, Imamura A, Toyama R, Mukai S, Fujiki Y, Tsukamoto T, Osumi T, Orii T, Wanders J A, Kondo N. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. Hum Molec Genet. 8:1999;1077-1083.
64. Liu Y, Bjorkman J, Urquhart A, Wanders R JA, Crane D I, Gould S J. PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders. Am J Hum Genet. 65:1999;621-634.
65. Honsho M, Tamura S, Shimozawa N, Suzuki Y, Kondo N, Fujiki Y. Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. Am J Hum Genet. 63:1998;1622-1630.
66. South S T, Gould S J. Peroxisome synthesis in the absence of preexisting peroxisomes. J Cell Biol. 144:1999;255-266.
67. Matsuzono Y, Kinoshita N, Tamura S, Shimozawa N, Hamasaki M, Ghaedi K, Wanders R JA, Suzuki Y, Kondo N, Fujiki Y. Human PEX19:cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. Proc Natl Acad Sci. 96:1999;2116-2121.
68. Santos M J, Imanaka T, Shio H, Small G M, Lazarow P B. Peroxisomal membrane ghosts in Zellweger syndrome - Aberrant organelle assembly. Science. 239:1988;1536-1538.
69. Lin Y, Sun L, Nguyen L V, Rabuchinski R A, Goodman H M. The Arabidopsis seeds. Science. 284:1999;328-330.
70. Purdue P E, Zhang J W, Skoneczny M, Lazarow P B. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nature Genet. 15:1997;381-384.
71. Motley A M, Hettema E H, Hogenhout E M, Brites P, ten Asbroek A LMA, Wijburg F A, Baas F, Heijmans H S, Tabak H F, Wanders R JA, Distel B. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nature Genet. 15:1997;377-380.
72. Neer E J, Schmidt C J, Namudripad R, Smith T F. The ancient regulatory-protein family of WD-repeat proteins. Nature. 371:1994;297-300.
73. Moser A B, Walton D S, Braverman N, Moser H W. The missense allele (A218V) in the rhizomelic chondrodysplasia punctata gene is associated with a milder phenotype. Ann Neurol. 42:1997;515.
74. Espeel M, Mandel H, Poggi F, Smeitink J AM, Wanders R JA, Kerckaert I, Schutgens R BH, Saudubray J M, Poll-The B T, Roels F. Peroxisome mosaicism in the livers of peroxisomal deficiency patients. Hepatology. 22:1995;497-504.
75. Roels F, Tytgat T, Bekeb S, Giros M, Espeel M, dePrest B, Kerckaert I, Pampols T, Rogiers V. Peroxisome mosaics in the liver of patients and the regulation of peroxisome expression in rat hepatocyte cultures. Ann NY Acad Sci. 804:1996;502-515.
76. Mandel H, Espeel M, Roels F, Sofer N, Luder A, Iancu T C, Aizin A, Berant M, Wanders R JA, Schutgens R BH. A new type of peroxisomal disorder with variable expression in liver and fibroblasts. J Pediatr. 125:1994;549-555.
77. Pineda M, Giros M, Roels F, Espeel M, Ruiz M, Moser A, Moser H W, Wanders R JA, Pavia C, Conill J. Diagnosis and follow-up of a case of peroxisomal disorder with peroxisomal mosaicism. J Child Neurol. 16:1999;434-440.
78. Kaufmann W E, Theda C, Naidu S, Moser A B, Moser H W. Zellweger-like neuronal migration abnormality in a patient with an isolated defect of peroxisomal fatty acid oxidation. Ann Neurol. 30:1991;497a-498a.
79. Ofman R, Hettema E H, Hogenhout E M, Caruso U, Muijsers A O, Wanders R JA. Acyl-CoA:dihydroxyacetonephosphate acyltransferase: Cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum Molec Genet. 7:1998;847-853.
80. Clayton P T, Eckhardt S, Wilson J, Hall C M, Yousuf Y, Wanders R JA, Schutgens R BH. Isolated dihydroxyacetonephosphate acyltransferase deficiency presenting with developmental delay. J Inher Metab Dis. 17:1994;533-540.
81. Elias R E, Mobassaleh M, Hajra A K, Moser A B. Developmental delay and growth failure caused by a peroxisomal disorder, dihydroxyacetone phosphate acyltransferase (DHAP-AT) deficiency. Am J Med Genet. 80:1998;223-226.
82. Roels F, Espeel M, DeCraemer D. Liver pathology and immunocytochemistry in congenital peroxisomal disease: A review. J Inher Metab Dis. 14:1991;853-875.
83. Chang C C, South S, Warren D, Jones J, Moser A B, Moser H W, Gould S J. Metabolic control of peroxisome abundance. J Cell Sci. 112:1999;1579-1590.
84. Schram A, Golfischer S, vanRoermund C WT, Brouwer-Kelder E M, Collins J, Hashimoto T, Heymans H SA, van den Bosch H, Schutgens R BH, Tager J M, Wanders R JA. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci USA. 84:1987;2494-2496.
85. Purdue P E, Yang X, Lazarow P B. Pex18p and Pex21p, a novel pair of related peroxins essential for peroxisomal targeting by the PTS2 pathway. J Cell Biol. 143:1998;1859-1869.
86. Poulos A S, Christodoulou J, Chow C W, Goldblatt J, Paton B C, Suzuko Y, Shimozawa N. Peroxisomal assembly defects: Clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J Pediatr. 127:1995;596-599.
87. Moser H W. Genotype-phenotype correlations in peroxisomal disorders. Dev Brain Dysfunct. 10:1997;282-292.